Background: The Pediatric Outcomes Data Collection Instrument (PODCI) is a validated quality-of-life questionnaire with 6 domains designed to provide a standardized method of measuring outcomes in pediatric musculoskeletal conditions. To our knowledge there are no reports on its use in children with multiple hereditary exostosis (MHE). Questions/Purposes: Most published studies on MHE patients have described the efficacy of specific surgical techniques or the specification of deformities. Little is known about the general health status of pediatric patients, the severity of pain, loss of function, and how MHE influences the activities of daily life. We aim to assess the functional levels of MHE pediatric patients with PODCI questionnaire. Patients and Methods: As a cross-sectional study, we prospectively administered PODCI to 34 pediatric patients diagnosed with MHE and their families. The score distributions were compared with values published earlier for children and adolescents without musculoskeletal disorders using the Student and Welch t tests. Parents and adolescents’ reports were compared using Wilcoxon signed rank test. Physical examination and PODCI score relation were evaluated by Spearman test. Results: Children with MHE have significantly lower scores (P<0,05) in comparison with unaffected children in all domains using the Student and Welch t test. Parents score differs from children score with statistically relevance in pain and comfort domain (P<0,5). The Spearman test showed a negative correlation between physical examination and PODCI score with statistical significance. Conclusions: These results point towards PODCI’s capacity in evaluating functional outcomes of pediatric patients with MHE. Level of Evidence: Diagnostic Study, Level III.

Objective: To present the epidemiological profile of bone and soft tissue tumors that affect the elbow region treated at an oncology referral center in Brazil. Methods: Retrospective observational case series study to evaluate the results of elbow cancer undergoing clinical and/or surgical treatment with the first visit from 1990 to 2020. The dependent variables were benign bone tumor, malignant bone tumor, benign soft tissue tumor, malignant soft tissue tumor. Independent variables were sex, age; presence of symptoms (pain/increase in local volume/fracture); diagnosis; treatment and recurrence. Results: In total, 37 patients were included, 51.35% of whom were female, with a mean age at diagnosis of 33.5 years. Soft tissue neoplasms correspond to 51% of cases against 49% of bone tumors. Among the symptoms, the general prevalence of pain was 56.75%, the general increase in local volume occurred in 54.04% of the patients and the presence of fractures in 13.43%. Surgical treatment occurred in 75.67% of cases and recurrence in 16.21% of cases. Conclusion: The tumors that affect the elbow in our series correspond mostly to benign tumors, involving bone or soft tissues, with a higher occurrence in young adult patients. Level of Evidence IV, Case Series.

BACKGROUND: The Hip Sports Activity Scale (HSAS) is a hip-specific instrument for assessing the present levels of physical activity among patients with femoroacetabular impingement (FAI) syndrome. When evaluating treatment outcomes in patients with FAI syndrome, it is necessary to use joint-specific instruments and ones that can evaluate the levels of physical activity in these patients, such as the HSAS-Brazil. OBJECTIVE: To validate the HSAS-Brazil among a group of physically active patients after arthroscopic treatment of FAI syndrome. DESIGN AND SETTING: Cross-sectional research of quantitative and qualitative types using data obtained from July 2018 to October 2019. METHODS: A total of 58 patients of both genders diagnosed with FAI syndrome and who had undergone hip arthroscopy participated in this research. To establish reliability and validity, patients first answered the Brazilian versions of the 12-Item Short-Form Health Survey (SF-12), Nonarthritic Hip Score (NAHS), and HSAS; after a 48-hour interval, they answered the HSAS-Brazil again. RESULTS: For test-retest reliability, the interclass correlation was 0.908 (P < 0.001). The HSAS-Brazil correlated to the NAHS-Brazil (r = 0.63, P < 0.001), as well as the SF-12 (Physical Health) (r = 0.42, P = 0.001). CONCLUSION: The HSAS-Brazil was validated and proved to be a reliable and valid scale to assess sports activity levels in physically active patients with FAI syndrome after arthroscopic treatment.

Objective: Characterizing ankle tumors, presenting the epidemiological profile of these lesions. Methods: Retrospective observational case series study to evaluate the results of clinical and/or surgical treatments of patients with ankle tumors whose first visit occurred from 1990 to 2020. The dependent variables were: benign bone tumor, malignant bone tumor, benign soft tissue tumor, malignant soft tissue tumor, and infection. The independent variables were: sex, age; presence of symptoms (pain/local volume increase/fracture), duration of symptoms until treatment, diagnosis, treatment, and recurrence. Results: In total, 70 patients were included-58.5% were women, with a mean age at the time of diagnosis of 21.66 years. Among all cases, 76% were bone tumor, 14% were soft tissue tumor, and 10% were infection. The mean age at the time of diagnosis was 21.7 ± 2.29 years. The overall prevalence of pain was 77.1%. In total, 55.6% patients had a general local volume increase 13.4% had fractures. The mean time from symptoms to treatment was 17.4 ± 4.61 months and the mean diagnosis time was 10.13 ± 0.86 months. Of all cases, 73.44% underwent surgical treatment and 22.64% had recurrence. Conclusion: In this series, ankle tumors corresponded mainly to bone tumors. Benign tumors were the most prevalent type of tumor and the highest occurrence was among young people. Level of Evidence IV, Case Series.

Durante as últimas décadas vários instrumentos, questionários e escalas, foram desenvolvidos para avaliar a função do paciente com dor no quadril. Esses instrumentos representam um método objetivo de medida da qualidade do tratamento recebido pelo paciente. Neste contexto, o presente artigo, tem como questão norteadora: Quais instrumentos de avaliação da qualidade de vida referente ao quadril estão disponíveis atualmente na literatura? O objetivo deste artigo foi realizar uma revisão bibliométrica dos instrumentos de avaliação da qualidade de vida utilizados mundialmente na ortopedia referente ao quadril. Existem instrumentos de avaliação da qualidade de vida genéricos e específicos. Os instrumentos específicos para quadril dividem-se em dois grupos: instrumentos específicos para paciente com e sem doença articular degenerativa. Os principais instrumentos genéricos utilizados são o 36-Item Short-Form Health Survey (SF-36) e o 12-Item Short-Form Health Survey (SF-12). Para avaliação de pacientes com doença articular degenerativa estão disponíveis os seguintes questionários: (i) Merle D’Aubigné e Postel; (ii) Charnley-Merle D’Aubigne; (iii) Western Ontario and McMaster Universities (WOMAC); (iv) WOMAC reduzido; (v) Mayo Hip Score; (vi) Oxford Hip Score (OHS); (vii) Hip Disability and Osteoarthritis Outcome Score (HOOS); (viii) Hip Rating Questionnaire (HRQ); (ix) Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH); (x) Harris Hip Score (HHS); (xi) Forgotten Joint Score (FJS). Para avaliação de pacientes sem doença articular degenerativa pode-se utilizar os seguintes questionários: (i) Harris Hip Score Modificado (HHSM); (ii) Hip Outcome Score (HOS); (iii) Nonarthritic Score Hip (NAHS); (iv) Hip Sports Activity Scale (HSAS). A associação de um instrumento de qualidade de vida genérico a um instrumento específico para quadril é fundamental para a correta avaliação e tomada de decisão referente ao cuidado clínico do paciente, além de favorecer o intercâmbio de informações no meio assistencial e acadêmico.